Atrial Fibrillation (AF) is a condition where the heart beats irregularly and sometimes too fast. This study looks at real-world use of catheter ablation technologies to treat two types of AF: Paroxysmal AF (PAF), which stops on its own in less than 7 days, and Persistent AF (PsAF), which lasts more than 7 days. The study aims to see how safe and effective these treatments are over time. Ablation is a procedure where doctors use heat to destroy small areas of heart tissue that cause the irregular heartbeat. This study will track patients before the procedure, during the procedure, and several times after, up to one year.
- Study visits occur pre-ablation, during the procedure, at 10-12 weeks, 6 months, and 1 year post-procedure.
- Participants must be 18 or older and not in another clinical trial.
- Participants will have regular heart monitoring and doctor visits.